Table 3.
Follow-up diagnoses and outcome measures for 348 primary care patients screened at baseline for psychiatric disorders and who reported no psychiatric treatment in the year before screening, by disorder group at baseline (in weighted percentages)a
Major depressive | Generalized anxiety | Alcohol or | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
disorder |
or panic disorder |
drug use disorder |
Bipolar disorder |
|||||||||||||
Follow-up diagnosis |
95% | 95% | 95% | 95% | ||||||||||||
or outcome | Yes | No | AOR | CI | Yes | No | AOR | CI | Yes | No | AOR | CI | Yes | No | AOR | CI |
Diagnosisb | ||||||||||||||||
Major de- | 62 | 13 | 9.7 | 4.2 | 47 | 16 | 3.7 | 1.6 | 25 | 17 | 3.9 | 1.3 | 23 | 18 | 1.3 | .4 |
pressive | to | to | to | to | ||||||||||||
disorder | 22.4 | 8.6 | 12.3 | 4.0 | ||||||||||||
Generalized | 21 | 5 | 3.9 | 1.4 | 17 | 6 | 3.6 | 1.1 | 15 | 6 | 4.5 | 1.1 | 13 | 7 | 1.4 | .3 |
anxiety | to | to | to | to | ||||||||||||
or panic | 11.4 | 12.2 | 19.2 | 5.8 | ||||||||||||
disorder | ||||||||||||||||
Substance- | 2 | 1 | 3.3 | .2 | 0 | 1 | — c | 9 | 1 | 31.9 | 2.4 | 6 | 1 | 26.6 | .7 | |
related | to | to | to | |||||||||||||
disorder | 46.3 | 417.6 | 972.7 | |||||||||||||
Lifetime | 22 | 7 | 2.9 | 1.0 | 12 | 8 | 1.6 | .4 | 25 | 7 | 5.4 | 1.7 | 40 | 6 | 8.0 | 2.7 |
bipolar | to | to | to | to | ||||||||||||
spectrum | 8.1 | 6.2 | 17.1 | 23.6 | ||||||||||||
disorder | ||||||||||||||||
Any of the | 69 | 23 | 6.1 | 2.7 | 58 | 26 | 3.3 | 1.4 | 40 | 27 | 3.3 | 1.2 | 52 | 26 | 2.9 | 1.1 |
above | to | to | to | to | ||||||||||||
13.9 | 7.8 | 8.6 | 7.4 | |||||||||||||
Mental | ||||||||||||||||
functioning | ||||||||||||||||
SF-12 MCSd | 35.8± | 50.3± | −14.8e | −19.7 | 41.4± | 49.3± | −8.1e | −12.2 | 46.8± | 48.9± | −4.6e | −9.2 | 43.2± | 49.1± | −5.1e | −11.3 |
score | 2.4 | .6 | to | 2.2 | .6 | to | 2.3 | .7 | to | 3.4 | .6 | to | ||||
(M±SE) | −10.0 | −4.0 | −.01 | 1.2 | ||||||||||||
SDS scoref | 7.9± | 3.0± | 5.1e | 3.1 | 6.6± | 3.3± | 3.6e | 1.4 | 5.2± | 3.3± | 3.0e | 1.0 | 4.7± | 3.4± | .8e | −1.6 |
(M±SE) | 1.0 | .3 | to | 1.2 | .3 | to | 1.0 | .3 | to | 1.3 | .3 | to | ||||
7.0 | 5.8 | 5.1 | 3.2 | |||||||||||||
Poor or fair | 63 | 24 | 6.2 | 2.7 | 64 | 26 | 6.1 | 2.4 | 44 | 27 | 2.6 | .97 | 51 | 27 | 2.6 | .9 |
emotional | to | to | to | to | ||||||||||||
health | 14.4 | 15.5 | 6.8 | 7.1 | ||||||||||||
Physical | ||||||||||||||||
functioning | ||||||||||||||||
SF-12 PCSd | 36.6± | 39.8± | −2.8e | −7.1 | 36.4± | 39.7± | −3.1e | −6.8 | 40.3± | 39.8± | .6e | −3.6 | 37.8± | 39.7± | −.9e | −6.5 |
score | 2.2 | .7 | to | 2.3 | .7 | to | 2.1 | .8 | to | 2.9 | .7 | to | ||||
(M±SE) | 1.5 | .6 | 4.8 | 4.8 | ||||||||||||
Poor or fair | 86 | 52 | 8.2 | 2.3 | 74 | 54 | 3.0 | 1.0 | 51 | 55 | 1.2 | .5 | 57 | 55 | 1.1 | .4 |
general | to | to | to | to | ||||||||||||
health | 28.9 | 8.9 | 2.9 | 3.2 | ||||||||||||
Medical | 1.7± | 1.2± | .5e | −.3 | 1.9± | 1.2± | .3e | −.5 | 2.1± | 1.1± | .9e | −.2 | 1.0± | 1.3± | −.1e | −.6 |
comorbidity | .4 | .1 | to | .4 | .1 | to | .6 | .1 | to | .2 | .1 | to | ||||
scoreg | 1.3 | 1.0 | 2.0 | .5 | ||||||||||||
(M±SE) | ||||||||||||||||
Health care utilizationht |
||||||||||||||||
Medical only | 8.2± | 7.7± | −.8e | −3.5 | 8.3± | 7.8± | −.9e | −3.9 | 5.5± | 7.8± | −1.4e | −4.6 | 7.7± | 7.8± | −.03e | −3.2 |
Outpa- | 1.3 | .5 | to | 1.8 | .5 | to | 1.3 | .6 | to | 1.6 | .5 | to | ||||
tient | 1.9 | 2.0 | 1.8 | 3.1 | ||||||||||||
visits (M±SE) |
||||||||||||||||
Any ER | 39 | 28 | 1.4 | .6 | 41 | 28 | 1.7 | .7 | 39 | 27 | 2.6 | 1.01 | 35 | 28 | 1.3 | .5 |
visits | to | to | to | to | ||||||||||||
3.1 | 4.2 | 6.7 | 3.7 | |||||||||||||
Any hos- | 9 | 12 | .4 | .1 | 11 | 12 | .4 | .1 | 19 | 11 | 2.0 | .6 | 7 | 12 | .7 | .1 |
pital ad- | to | to | to | to | ||||||||||||
missions | 2.0 | 3.1 | 6.2 | 3.4 | ||||||||||||
Psychiatric treatment |
||||||||||||||||
Outpatient | 2.4± | 1.2± | .4e | −2.3 | 2.9± | 1.2± | .6e | −1.9 | .4± | 1.4± | −.3e | −1.3 | 1.7± | 1.3± | .3e | −2.6 |
visits | 1.0 | .4 | to | 1.4 | .4 | to | .2 | .4 | to | 1.0 | .4 | to | ||||
(M±SE) | 3.1 | 3.2 | .7 | 3.2 | ||||||||||||
Any ER | 12 | 3 | 6.4 | 1.1 | 21 | 3 | 8.5 | 2.0 | 8 | 3 | 8.0 | 1.3 | 7 | 4 | 3.0 | .3 |
visits | to | to | to | to | ||||||||||||
36.0 | 36.9 | 49.8 | 27.1 | |||||||||||||
Any hos- | 15 | 4 | 3.8 | .8 | 21 | 4 | 4.2 | .9 | 5 | 4 | 2.0 | .3 | 10 | 4 | 3.1 | .7 |
pital ad- | to | to | to | to | ||||||||||||
missions | 19.0 | 19.3 | 12.6 | 13.7 |
The percentages are weighted to account for attrition at follow-up. The adjusted odds ratios (AORs) are for the group with a positive screen; they were generated from a logistic regression that used weighted data and controlled for gender, age group, ethnicity (Hispanic versus non-Hispanic), education, income, and time between baseline and follow-up interview. Ns for some screening diagnoses sum to less than 348 because of missing data.
Based on the Structured Clinical Interview for DSM-IV
The test could not be calculated because of a zero cell.
The Medical Outcomes Study Short-Form Health Survey (SF-12) mental component summary (MCS) and physical component summary (PCS) scores are expressed as T scores in relation to national norms (mean±SD=50±10), with higher scores indicating better functioning.
Expected score difference (with 95% confidence interval) for the group with the positive screen; generated from a linear regression that used weighted data and controlled for gender, age group, ethnicity (Hispanic versus non-Hispanic), education, income, and time between baseline and follow-up interview.
Sheehan Disability Scale. Possible scores range from 0 to 20, with higher scores indicating greater functional impairment.
Charlson Comorbidity Index score. Higher scores indicate greater medical comorbidity. Based on ICD-9 codes in patients’ records during the year before follow-up. Sample range, 0–11
Data from hospital administrative records during the year before follow-up. ER, emergency room